Sunitinib and its intermediate

Sunitinib and its intermediate

144143-96-4

C₂₃H₂₄N₂O₄S.CH₄O₃S

MFCD08141807

4-[[2-butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate ; eprosartan monomethanesulfonate ; sunitinib and its intermediate ; eprosartan mesylate ; 4-({2-butyl-5-[(1e)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1h-imidazol-1-yl}methyl)benzoic acid ; eprosartan methanesulfonate ; eprosartan mesylate, >=99% ; (αe)-α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene]-2-thiophenepropanoic acid monomethanesulfonate ; (e)-α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene]-2-thiophenepropanoic acid methanesulfonate ; eprosartan mesylate (50 mg) ((e)-2-butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate)